MYRIAD GENETICS, INC. Cash and Restricted Cash
MYRIAD GENETICS, INC. (MYGN) had Cash and Restricted Cash of $116.80 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-31
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $116.80M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $126.00M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $151.30M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $154.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $116.80M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $126.00M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $151.30M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $154.80M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $83.70M 10-Q · filed 2026-07-31 | |
| 2025-03-31 | $101.00M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $111.90M 10-Q · filed 2026-07-31 | |
| 2024-09-30 | $109.80M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $101.20M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $105.60M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $140.90M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $85.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $112.70M 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $63.10M 10-Q · filed 2024-05-08 | |
| 2022-12-31 | $66.40M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $110.70M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $106.20M 10-Q · filed 2023-08-04 | $105.20M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $165.60M 10-Q · filed 2023-05-04 | $165.20M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $258.80M 10-K · filed 2025-02-28 | $258.40M 10-K · filed 2022-02-25 |
| 2021-09-30 | $295.20M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $118.40M 10-Q · filed 2022-08-05 | |
| 2021-03-31 | $148.90M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $117.00M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $118.30M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $163.70M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $121.00M 10-Q · filed 2021-05-05 | |
| 2019-12-31 | $81.20M 10-Q · filed 2021-11-04 | |
| 2019-09-30 | $89.90M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $93.20M 10-K · filed 2023-03-01 | |
| 2019-03-31 | $84.90M 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $90.60M 10-Q · filed 2020-02-07 | |
| 2018-09-30 | $93.30M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $110.90M 10-K · filed 2022-02-25 | |
| 2017-06-30 | $102.40M 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |